Prof Pedja Kovacevic, MD, PhD, FCCP, FCCM is an expert in Critical care at University Clinical Centre of the Republic Srpska (Bosnia and Herzegovina). As of October 2026, ScienceLeadR ranks Pedja Kovacevic in the top 1% of experts in Bosnia and Herzegovina for Pneumonia, COVID-19 and Coronavirus Infections. Pedja Kovacevic has authored 105 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 364 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Pedja Kovacevic, MD, PhD, FCCP, FCCM University Clinical Centre of the Republic Srpska Bosnia and Herzegovina
364 ScienceLeadR Reputation 364
Network Map

Critical care

Subspecialties: Infectiology - Public Health - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026
Source: PubMed

University of Banja Luka

2006 - 2026

University Clinical Centre of the Republic Srpska

2019 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 105

Citations

Citations: 847 1st author: 30 Last author: 26 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Editorial: Extracorporeal organ support: innovations and challenges in critical care.
PMID 42948080 — extracorporeal membrane oxygenation, critical care
Front Med (Lausanne)20260
Population Pharmacokinetics of Amikacin and Monte Carlo Simulation Study in Critically Ill Septic Patients Undergoing Continuous Renal Replacement Therapy with CytoSorb ® or oXiris ®.
PMID 42942835 — continuous renal replacement therapy, critical illness, amikacin, therapeutics, renal replacement therapy, pharmacokinetics
Pharmaceutics20260
Modified NUTRIC score and clinical outcomes in critically ill medical patients: A prospective cohort study in Bosnia and Herzegovina.
PMID 42906295 — mortality, laboratories, biomedical research, cohort studies, critical illness, intensive care units, ventilation
Biomol Biomed20260
Saccharomyces boulardii for the Prevention of Antibiotic-Associated Diarrhea in Hospitalized Patients Receiving Antibiotics: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Trial.
PMID 42792018 — confidence intervals, saccharomyces boulardii, odds ratio, saccharomyces, probiotics, therapeutics, diarrhea
Antibiotics (Basel)20260
Consensus statement for managing patients with ARDS in low-resource settings: a Delphi study.
PMID 42729909 — critical care
Ann Intensive Care20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Director: 1

By phase:

N/A 4

By status:

Recruiting 2
Completed 1
Enrolling by invitation 1

By type:

Observational 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Standardising Terminology Classification Diagnostic Recognition and Reporting of Patient ventilator Interactions Protocol for an International Delphi Consensus Study
NCT07638540 — delphi technique, classification, research, ventilation, education
N/AEnrolling by invitation2026
Population Pharmacokinetic Model of Amikacin and Vancomycin in Critically Ill Patients
NCT06261164 — research design, shock, septic, pharmaceutical preparations, vancomycin, sepsis, critical illness, amikacin, diagnosis, therapeutics
N/ARecruiting2024

LeadR Networks

Main global connection map